re: XSPA

__
XpresSpa Group Inc. shares were up 22% to $2.32 in heavy trade after the company said it has partnered with HyperPointe in connection with XpresCheck, its newly formed business unit that will provide Covid-19 screening and testing in U.S. airports.
Volume for the stock was 157 million shares at 1:30 p.m. EDT , compared with 65-day average volume of 34 million shares.
The health and wellness company said HyperPointe is providing a full range of support that extends beyond marketing.
XpresSpa said it has worked to help XpresCheck design a workflow with the capacity to test thousands of people each week with minimal disruption to the workday. The company said its technology team is integrating the XpresCheck workflow with AdvancedMD's Practice Management and EHR solution for online appointment scheduling, patient intake, lab integration, medical billing and reporting analytics.
XpresCheck said it has begun construction and intends to start a pilot program at New York's John F. Kennedy International Airport Terminal 4 by the end of June, offering testing for airline employees, contractors and workers, airport concessionaires and their employees, Transportation Security Administration officers, and U.S. Customs and Border Protection agents.